Public notice which we propose to publish through news’ papers provides necessary information/clarification on the Company’s perspective.Continue reading
There is malicious news being spread in news media and social media platforms about the Company to the effect that the Company is violating the Covid-19 Safety Guidelines published by the State Government. It is also alleged that more than 100 employees have tested positive for Covid-19 infection and the Company is continuing the manufacturing operations by concealing the Employees Covid-19 Positive cases. Some of the people without having proper information/knowledge made complaints to Nelamangala Tahsildar, Bangalore Rural DC and other authorities. Based on such complaints Nelamangala Taluk administration had visited the Factory on last Thursday (06.05.2021) and directed the Company to shut down the operations in view of some Covid-19 Positive employees. Accordingly the Company has shut-down the operations and provided necessary clarifications to the Administrative Authorities.
The Company hereby places before general public the correct information for their understanding and to clear any mis-conception in this regard.
Wintac Limited is engaged in the manufacture of pharmaceutical products and is an 100% EOU Unit operating in this location for the last 25 years. The company manufactures injections and ophthalmic products and four of our products are used in the treatment of Covid infected patients. The manufacturing plant is of International Standards and has very good manufacturing practices and the Manufacturing Area is of controlled atmosphere with high degree of clean air concepts and we have adequate controls and systems to ensure that the area is free from any microbials/bacteria’s which is a critical requirement for manufacture of sterile injections. Therefore, the chances of presence or spread of Covid-19 virus inside factory manufacturing area is absolutely not there.
However, some of the employees in the laboratory area may have got the infections outside the factory and when we noticed that they have some symptoms, like cold, cough and fever, we closed down the lab for 4 days and subjected all the lab employees for RTPCR Test. Some of the employees have tested on their own at the recognized laboratories and there were 60 employees who have tested positive for the Covid-19 virus. Employees with covid positive reports and also who have symptoms were strictly prohibited from entering the factory premises and were advised to be home quarantined/isolated to avoid spreading of infection to their family members. They were also advised to consult the Doctors for proper medication and treatment.
Even after the testing we waited for 3 more days to ascertain if any of the employees who have tested negative have any symptoms and allowed only such employees who tested negative and no symptoms thereafter. In other words, we have only people who are free from Covid, working in the Company.
Further, the RTPCR Tests are done through ICMR recognized Laboratory and before the testing, employees are registered with SRF Numbers and Positive cases are identified with BUID and the recognized Laboratory sends the positive reports directly to the Government Authorities. Therefore there is no question of concealing any information about Employees Testing Positive.
The Company has also put in place a strict Covid-19 safety procedures/protocols to avoid spread of infection within the factory premises. Covid Safety Committee, formed by the Company with technical experts, overseas the adherence of Covid Protocols by the employees. Some of the measures followed includes (i) double masking for the employees, (ii) strict social distancing by advising some of the employees to work from home wherever feasible and split the laboratory work in two shifts, (iii) Thermal screening, monitoring and sanitization of employees at the time of entry and during lunch time, (iv) cleaning and fogging of common areas/canteens/vehicles twice a day, (v) creating additional canteen space with tents to ensure social distance during lunch time, etc.
As we fall under the essential service category, particularly producing products required for treatment of covid infected patients, the Company is continuing operations by strictly following all the Covid safety measures and guidelines prescribed by the statutory authorities, State and Central Government. The Company is also testing the employees aggressively to ensure that there are no infected people inside the factory. The Company has also extended various welfare measures for the employees like (i) compensation of ₹ 25 lakhs per employee and ₹ 10 each of family member of employee in the event of untoward death of employee due to Covid infection, (ii) free canteen, (iii) free covid insurance policy to cover the covid treatment cost of employees and their family members upto Rs.12 lakh per family, etc.
The Company has a duty and moral obligation to work and ensure continued supply of medicines for the desperate patients who are fighting for their life against this COVID-19. We have explained the issues to the concerned Authorities and working with them to clear their mis-conception and restart the Operations at the earliest.
For Wintac Limited
Chief Operating Officer
Place: Nelamangala, Bangalore Rural
Wintac Limited provided Oxygen Concentrators to Nelamangala Taluk Administration for Local Govt. Hospital.
At the pandemic during second wave of Covid, when hospitals were facing a dire shortage of Oxygen cylinders and concentrators. The record increase of COVID positive patients and fatalities per day, we at Wintac Limited had responded in time to stand strong beside our saviours who were risking their lives to save Covid patients by supporting ₹8.5 lakhs worth oxygen concentrators through this mission and helped save Covid patients who desperately needed oxygen support for survival..
We have donated 10 oxygen concentrators to Nelamangala taluk administration for using at local Govt. hospital. Oxygen concentrators support human breathing by extracting high-concentration oxygen from the air and are commonly used in home medical care under the direction of doctors.
Wintac Limited, a pharmaceutical company and an essential service provider, apart from manufacturing drugs for the treatment of Covid patients during this difficult pandemic time, has stood up in supporting the critical Covid patients by donating the oxygen concentrators.
ವಿಂಟಾಕ್ ಲಿಮಿಟೆಡ್ ನಿಂದ ನೆಲಮಂಗಲ ತಾಲ್ಲೂಕು ಆಡಳಿತಕ್ಕೆ, ಸ್ಥಳೀಯ ಸರ್ಕಾರಿ ಆಸ್ಪತ್ರೆಗಾಗಿ ಆಮ್ಲಜನಕ ಸಾಂದ್ರಕ ಕೊಡುಗೆ.
ಕೋವಿಡ್ ಎರಡನೇ ಸಾಂಕ್ರಾಮಿಕ ರೋಗ ಸಮಯದಲ್ಲಿ, ದಿನದಿಂದ ದಿನಕ್ಕೆ COVID ಸಕಾರಾತ್ಮಕ ರೋಗಿಗಳ ದಾಖಲೆಯ ಹೆಚ್ಚಳ, ಸಾವುನೋವುಗಳು, ಮತ್ತು ಆಸ್ಪತ್ರೆಗಳು ಆಮ್ಲಜನಕ ಉಪಕರಣದ ತೀವ್ರ ಅಗತ್ಯವನ್ನು ಎದುರಿಸುತ್ತಿರುವಾಗ, ವಿಂಟಾಕ್ ಲಿಮಿಟೆಡ್ ನಿಂದ ನಾವು, ಸಮಯಕ್ಕೆ ಸರಿಯಾಗಿ ಪ್ರತಿಕ್ರಿಯಿಸಿದ್ದೆವು. ₹ 8.5+ ಲಕ್ಷ ಮೌಲ್ಯದ ಆಮ್ಲಜನಕದ ಸಾಂದ್ರಕಗಳನ್ನು ನೀಡುವ ಮೂಲಕ ಕೋವಿಡ್ ರೋಗಿಗಳನ್ನು ರಕ್ಷಿಸಲು ತಮ್ಮ ಪ್ರಾಣವನ್ನು ಪಣಕ್ಕಿಟ್ಟು ಹೋರಾಡುವ ‘ಕೊರೊನಾ ವಾರಿಯರ್ಸ್ ರನ್ನು ನಾವು ಬೆಂಬಲಿಸಿದೆವು, ಇದು ಆಮ್ಲಜನಕದ ಅಗತ್ಯವಿರುವ ಕೋವಿಡ್ ರೋಗಿಗಳನ್ನು ಉಳಿಸಲು ಸಹಾಯವಾಗಬಹುದೆಂದು ನಾವು ಬಯಸುತ್ತೇವೆ.
ಆಮ್ಲಜನಕ ಸಾಂದ್ರಕಗಳು ಗಾಳಿಯಿಂದ ಹೆಚ್ಚಿನ ಸಾಂದ್ರತೆಯ ಆಮ್ಲಜನಕವನ್ನು ಹೊರತೆಗೆಯುವ ಮೂಲಕ ಮಾನವನ ಉಸಿರಾಟವನ್ನು ಬೆಂಬಲಿಸುತ್ತವೆ ಮತ್ತು ಇದನ್ನು ಸಾಮಾನ್ಯವಾಗಿ ವೈದ್ಯರ ನಿರ್ದೇಶನದಲ್ಲಿ ಮನೆಯ ವೈದ್ಯಕೀಯ ಆರೈಕೆಯಲ್ಲಿ ಬಳಸಲಾಗುತ್ತದೆ. ಈ ರೀತಿಯ 10 ಆಮ್ಲಜನಕ ಸಾಂದ್ರಕಗಳನ್ನು ನಾವು ನೆಲಮಂಗಲ ತಾಲ್ಲೂಕು ಆಡಳಿತಕ್ಕೆ ಸ್ಥಳೀಯ ಸರ್ಕಾರಿ ಆಸ್ಪತ್ರೆಗಾಗಿ ನೀಡಿದ್ದೇವೆ.
ವಿಂಟಾಕ್ ಲಿಮಿಟೆಡ್, ಅಗತ್ಯ ಸೇವೆ ಒದಗಿಸುವ ಒಂದು ಔಷಧೀಯ ತಯಾರಕ ಕಂಪನಿ. ಈ ಕಷ್ಟಕರ ಸಾಂಕ್ರಾಮಿಕ ಸಮಯದಲ್ಲಿ ಕೋವಿಡ್ ರೋಗಿಗಳ ಚಿಕಿತ್ಸೆಗಾಗಿ ಔಷಧಗಳನ್ನು ತಯಾರಿಸುವುದನ್ನು ಅದಷ್ಟೆ ಅಲ್ಲದೆ ಕೋವಿಡ್ ರೋಗಿಗಳಿಗೆ ಆಮ್ಲಜನಕದ ಸಾಂದ್ರತೆಯನ್ನು ನೀಡುವ ಮೂಲಕ ಬೆಂಬಲವಾಗಿ ನಾವು ನಿಂತಿದ್ದೇವೆ.
The Promoter of the Company, Veego Pharma LLC, USA, had made an application to Department
of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India seeking approval
to enhance its shareholding in Wintac Limited up to 100% which is a pre-requisite to proceed
with the delisting of Equity Shares of the Company in compliance with SEBI (Delisting of Equity
Shares) Regulations, 2009.
The Department of Pharmaceuticals has informed Veego Pharma that the Government has not
acceded to the proposal as one of the conditions of the previous approval dated 16.01.2018,
which required furnishing of annual compliance of the conditions of the said approval, has not
been complied with.
Veego Pharma has since complied with the said condition by filing the annual compliance report
for the financial year 2017-18 and has commenced the process of making a fresh application
seeking Government approval for enhancing Veego’s shareholding limits up to 100°/o in Wintac
As informed by our previous communication on February 28, 2019 the Promoter has re-affirmed
its intention to pursue the delisting proposal in compliance with the SEBI (Delisting of Equity
Shares) Regulations, 2019.
The disclosure is made pursuant to Regulation 30 of Securities and Exchange Board of
India (Listing obligations and disclosure requirements) Regulations, 2015